Health

Health - Overview - Market - Text web content

The table below highlights available market estimates and forecasts for health nanotechnology products. There are high levels of market share and predicted growth in areas such as cancer/clinical oncology (EUR 64 billion in 2019) and synthetic bone and tooth materials (hydroxyapatite, EUR 1 billion in 2019). Other technologies are currently only emerging but are expected to show a very high growth rate to 2019: dendrimers, proteomics, biomarkers and quantum dots for bio-reagents.

The relative proportions of the global market across the sub-sectors considered here (i.e. cancer, cardiovascular disease, infectious diseases and neurodegenerative diseases, data for diabetes being unavailable) are expected to change only gradually from 2012 to 2019. The largest share of sales is related to cancer treatment followed by central nervous system (CNS) products (largely including pharmaceuticals targeting neurodegenerative diseases) and products to prevent and counter infection (‘anti-infectives’). The global market for nano-pharmaceuticals is growing at a faster pace that the overall market for pharmaceuticals.

 

2014

2019

USD CAGR [2]

Source

Global

EUR (billion)

EUR (billion)

%

 

Total nanomedicine

186

498

16

BCC [1]

Total healthcare

73

184

12

GVR [3]

Total nano-diagnostics

29

109

24

BCC [1]

Total nano-pharmaceuticals

157

388

14

BCC [1]

         

Sub-sectors

EUR (billion)

EUR (billion)

%

 

Cancer

24.1

--

--

F&S [4]

Clinical oncology

 

64.4

12

GVR [5]

Cardiovascular

5.3

--

--

F&S [4]

Diabetes

5.0

--

--

F&S [4]

Infectious diseases

12.8

--

--

F&S [4]

Neurodegenerative diseases

8.3

--

--

F&S [4]

         

Applications

EUR (million)

EUR (million)

   

Drug delivery

117

201

7

BCC [1]

QD for biological reagents

18.6

410

77

BCC [1]

Biomarkers and detection

70

506

42

BCC [1]

MRI contrast agents (iron)

9.4

14.2

5

BCC [1]

Surface disinfectants

--

0.9

--

BCC [1]

Antimicrobial coatings

56

--

--

VDI [6]

Antibacterial lacquers

113

--

--

VDI [6]

Nano silver for antimicrobials

29

--

--

VDI [6]

Proteomics

--

108

 

BCC [1]

Hydroxyapatite (bones/teeth)

264

1008

26

BCC [1]

Dendrimer transfection reagents

0.7

6.6

51

BCC [1]

[1] BCC Research (2014), Nanotechnology in Medical Applications

[2] Compound annual growth rate CAGR based on USD figures (i.e. does not incorporate change in EUR/USD currency exchange rate)

[3] Estimate for 2012, forecast for 2020, CAGR for 2012-2020. Global View Research Inc.: http://www.grandviewresearch.com/industry-analysis/healthcare-nanotechology

[4] Frost & Sullivan, work undertaken for the NanoData project

[5] Forecast for 2020. Global View Research Inc.: http://www.grandviewresearch.com/industry-analysis/healthcare-nanotechology

[6] Estimate for 2013, VDI for BMBF https://www.bmbf.de/pub/nanoDE_Report_2013_englisch_bf.pdf